It is reported that NOD2 limited microbes-mediated immunomodulator in CTX-treated cancer; however, they only showed apoptosis data instead of tumor data in NOD2 knockout mice treated with bacterial oral gavage, which lack the direct evidence to show that NOD2 is a checkpoint for CTX therapy [38]. The gene discussed is NOD2; the disease is neoplasm.